doi:10.1016/j.vaccine.2024.126535Chenoa SankarJohanna C. MeyerMarione SchnfeldtHannah GunterHalima DawoodVictoria SekitiNaseera PickardLawrence MubaiwaDini MawelaSipho DlaminiElsevier LtdVaccine
The lead researcher on the trial of the Oxford vaccine carried out in South Africa, Professor Shabir Madhi, told CBS News on Monday that more than 13 variants of the coronavirus had been identified in the country since the start of the pandemic. He said the new one, 501.V2, which has ...
Johannesburg, South Africa — A small-scale study suggests the coronavirus variant first discovered in South Africa, which has now been found in 10 U.S. states, reduces the antibody protection provided by the Pfizer COVID-19 vaccine by about two-thirds. It's the latest worrying data on...
South Africa has approved the COVID-19 vaccine produced by the Chinese company, Sinovac. 2.5 million doses have been cleared for delivery, as South Africa battles a crippling third wave, which is overwhelming hospitals - especially in Johannesburg. The country reported 24,000 new...
Airfinity’s Q1 COVID-19 vaccine revenue forecast more accurate than market consensus Published by Airfinity May 12, 2022Read story South Africa's fifth wave potentially driven by new Omicron subvariants Published by Airfinity May 3, 2022Read story ECCMID2022: Day 3 Post-Conference Coverage Publish...
JOHANNESBURG, June 18 (Xinhua) -- South African Minister of Trade, Industry and Competition Ebrahim Patel on Saturday welcomed the World Trade Organization (WTO)'s agreement to waive COVID-19 vaccine patents, 20 months after the African nation proposed a broad waiver to combat the pandemic. ...
A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc/BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday. The study fou...
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. One was first discovered in Britain and South Africa.新的研究表明，由辉瑞和BioNTech生产的COVID-19疫苗...
There was a strong political commitment in South Africa to mobilize financial resources to respond to COVID-19, including for vaccine procurement and deployment, and the project will create an enabling environment that will promote the participation of other donors, multilateral development banks, and...
South Africa halted the rollout of the AstraZeneca-Oxford COVID-19 vaccine this week after a trial showed it did not prevent mild and moderate disease. Data on this vaccine has been confusing.